HUAWEI
24.3.2023 05:15:29 CET | Business Wire | Press release
Huawei recently held the Top 10 Trends of Data Center Facilities conference, themed "Smart DC, Building the Green Future". Fei Zhenfu, President of Huawei Data Center Facility Domain, released a white paper outlining Huawei's insights on data center facility trends that aim to promote sustainable development in the data center industry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230323005815/en/
Fei Zhenfu, President of Huawei Data Center Facility Domain, shared Huawei's insights on the top 10 data center facility trends. (Photo: Business Wire)
According to Mr. Fei, as global computing demand continues to grow exponentially in the digital intelligence era, there will be a surge in data center construction. To achieve carbon neutrality, the industry must prioritize energy conservation, carbon emission reduction, and green transformation. This presents both challenges and opportunities. Drawing from its experience and industry insights, Huawei has identified the following 10 trends:
Trend 1: Low Carbon
Data centers will adopt green, low-carbon solutions and utilize clean energy sources like PV, wind, and hydropower to minimize their carbon footprint. By 2027, green power utilization is expected to exceed 50%. Advanced energy conservation solutions and technologies, such as waste heat recovery, will be implemented to improve data center energy efficiency and recovery rates.
Trend 2: Sustainability
New sustainability indicators for data centers will be introduced, including renewable energy utilization, water usage effectiveness (WUE), carbon usage effectiveness (CUE), space usage effectiveness (SUE), grid usage effectiveness (GUE), material recovery rate, and lifetime contaminant emissions, in addition to the existing power usage effectiveness (PUE).
Trend 3: Fast Deployment
Data centers must be rapidly deployed to meet skyrocketing computing demands, with construction periods decreasing from 12 months to six months or less.
Trend 4: High Density
As chip performance and power consumption improve, the demand for high-density data centers will increase. Cloud data centers will become mainstream, and diversified computing collaboration will become the norm. Standard power density per IT rack will increase from 6–8 kW to 12–15 kW by 2027. Power density in supercomputing and intelligent computing centers will reach 30 kW or higher.
Trend 5: Elasticity
Future data centers will be more flexible regarding upgrades, with one generation of facilities supporting power evolution over two to three generations of IT equipment. A standard design will facilitate on-demand deployment and elastic capacity expansion.
Trend 6: Prefabrication
The prefabricated and simple architecture will tackle challenges like long construction periods and complex O&M faced by traditional data centers. In the future, a data center building will house over 1000 racks, and a campus will accommodate over 10,000 racks. The prefabricated design will shorten the construction period for a 1000-rack data center from 12 months to 6 months, enabling rapid delivery and on-demand deployment.
Trend 7: Storage and Backup Integration
Renewable energy and energy storage will be necessary for power-hungry data centers. Energy storage systems (ESSs) deployments in data centers will integrate short-term backup power systems to participate in frequency regulation and peak shaving, enhancing power grid stability. Peak shaving will also improve the grid usage effectiveness (GUE) so that more IT racks can be deployed to increase revenue.
Trend 8: Distributed Cooling
A distributed cooling system uses cooling sources for each data hall and adopts a redundancy configuration as required. In the future, distributed cooling systems will gradually replace centralized cooling as the preferred solution for large data centers due to their flexible architecture and high reliability.
Trend 9: Smart O&M
Smart O&M is crucial for enhancing data center resource utilization and reliability. Intelligent operations will automatically determine data center asset statuses to maximize asset value. Intelligent maintenance will identify faults and optimize energy conservation in real time to improve O&M efficiency, achieving predictive maintenance and optimal energy efficiency.
Trend 10: Security & Trustworthiness
As digitalization and intelligence advance, data centers will strengthen their hardware reliability, software security, system resilience, safety, privacy, and availability. AI technologies will implement predictive maintenance on components, devices, and systems at the hardware level. The hierarchical defense will be provided at the software level. A combination of software and hardware measures will boost data center reliability.
Moving forward, Huawei will strengthen technological innovation to lead industry development and offer more competitive products and solutions to build a solid digital foundation for a greener, low-carbon future for the data center industry.
For more information, please download the White Paper on the Top 10 Trends of Data Center Facilities at https://digitalpower.huawei.com/attachments/index/06be6a70172444d1a84f88b8e0db5c29.pdf
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230323005815/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom